Previous Close | 10.21 |
Open | 10.15 |
Bid | 10.43 x 1000 |
Ask | 11.45 x 1200 |
Day's Range | 10.08 - 10.59 |
52 Week Range | 7.80 - 23.21 |
Volume | |
Avg. Volume | 341,901 |
Market Cap | 686.657M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.05 |
Earnings Date | May 12, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 13.50 |
NEW YORK & LONDON & HONG KONG, May 25, 2022--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native SaaS solutions for investment managers, released more than 100 enhancements and new features for its Order and Execution Management System (OEMS) in Q1 2022, as the asset management community increasingly shifts towards solutions that address the complexities associated with managing sophisticated daily order flow.
NEW YORK & LONDON & HONG KONG, May 12, 2022--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-based investment management software and services, today announced financial results for the first quarter ended March 31, 2022.
Today we will run through one way of estimating the intrinsic value of Enfusion, Inc. ( NYSE:ENFN ) by estimating the...